# Author request: revised draft for review, not sent

Subject: Clarification of familiar-track identity and treatment metadata

Dear Matthew and David,

Thank you for making your recordings available. We are assessing whether the
release can support a focused follow-up: does VTA suppression change the
relationship between ripple recruitment and subsequent spatial firing, beyond
changes already occurring before the ripple? We have not computed this treatment
contrast.

The main question is whether each of the three experimental and three control
animals has recordings from the same familiar track/environment under both
saline and CNO. We can read the released drug and novel/familiar labels, but
cannot establish physical track identity from those labels alone.

Could you point us to an existing session key, or clarify:

1. Which sessions share a physical track/environment, and which track was used
   for pretraining?
2. What was the experience order on each track, including prior exposures not
   included in the release?
3. How were saline/CNO sessions allocated or ordered, and were CNO dose and
   injection-to-recording delay constant or session-dependent?
4. Are the release's experimental/control assignments correct for Con_1,
   Con_2, Con_3 and Exp_1, Exp_3, Exp_4?

We have prepared a 135-session inventory to make the session names easy to match.
You need not complete every row: an existing lookup table, or a short description
of rules and exceptions, would be very helpful. Familiar sessions are the priority;
we would not use novel-track comparisons as the primary treatment test. Please
leave anything unavailable as unknown.

No additional raw recordings are needed at this stage. If the familiar tracks
were not recorded under both treatments, that is useful to know too: we would
stop this comparison rather than assume that different tracks are interchangeable.

Best regards,
Florian

## Administration

Status: revised for user review on 2026-10-01. The user explicitly requested
that it remain unsent. Do not send or start a response deadline without fresh
approval.

Use the generated `author_metadata_template.csv` from the metadata preflight
as the proposed attachment. It preserves all 135 session identities and adds the
confirmation/allocation/source fields needed by the importer. The earlier
`kleinman_track_metadata_request.csv` has fewer columns. Do not prefill unknown
track identities, experience order, doses, timing or confirmations.

Internal attachment review: the release labels 93 sessions familiar and 42 novel.
These are inventory counts, not a verified same-track cohort or usable packet
count. An author response in prose may be transcribed into the importer schema
with its source reference, but unresolved values must remain missing.

Start the two-week response clock only on the actual send date. Allow one
clarification round, without resetting the clock. If the essential design remains
unsupported, record `blocked_metadata` and stop. No drug contrast is authorized
by approval to send this request.
